Compile Data Set for Download or QSAR
maximum 50k data
Found 1402 with Last Name = 'miura' and Initial = 't'
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50323472((R)-3-((2S,3S)-3-(2-(4-((2-aminoethyl)(ethyl)amino...)
Affinity DataKi:  0.100nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50323469((R)-3-((2S,3S)-3-(2-(4-((2-(dimethylamino)ethyl)(m...)
Affinity DataKi:  0.100nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50209559((4R)-3-[(2S,3S)-3-{[(2,6-dimethylphenoxy)acetyl]am...)
Affinity DataKi:  0.5nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50323470((R)-3-((2S,3S)-3-(2-(4-(2-(ethylamino)ethylamino)-...)
Affinity DataKi:  0.680nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50001073(CHEMBL3236067)
Affinity DataKi:  1nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50001072(CHEMBL3236066)
Affinity DataKi:  1.10nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50323468((R)-3-((2S,3S)-3-(2-(2,6-dimethyl-4-(methyl(2-(met...)
Affinity DataKi:  1.20nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50001070(CHEMBL3236064)
Affinity DataKi:  1.20nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50001069(CHEMBL3236063)
Affinity DataKi:  1.70nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50001071(CHEMBL3236065)
Affinity DataKi:  2.30nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50323473((R)-3-((2S,3S)-3-(2-(4-(ethyl(2-(ethylamino)ethyl)...)
Affinity DataKi:  4.20nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50001075(CHEMBL3236069)
Affinity DataKi:  4.30nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50001067(CHEMBL3236061)
Affinity DataKi:  4.40nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50001068(CHEMBL3236062)
Affinity DataKi:  4.80nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50323471((R)-3-((2S,3S)-3-(2-(4-(2-(diethylamino)ethylamino...)
Affinity DataKi:  5.10nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50001064(CHEMBL3236058)
Affinity DataKi:  5.5nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50001074(CHEMBL3236068)
Affinity DataKi:  5.70nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50323464((R)-3-((2S,3S)-3-(2-(4-(2-aminoethylamino)-2,6-dim...)
Affinity DataKi:  6.5nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50323467((R)-3-((2S,3S)-3-(2-(4-((2-aminoethyl)(methyl)amin...)
Affinity DataKi:  8.5nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50323465((R)-3-((2S,3S)-3-(2-(2,6-dimethyl-4-(2-(methylamin...)
Affinity DataKi:  9.10nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50273749((R)-3-((2S,3S)-3-(2-(2,6-dimethyl-4-(pyridin-2-ylm...)
Affinity DataKi:  10nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50323474((R)-3-((2S,3S)-3-(2-(4-((2-(diethylamino)ethyl)(et...)
Affinity DataKi:  10nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50001065(CHEMBL3236059)
Affinity DataKi:  11nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50323466((R)-3-((2S,3S)-3-(2-(4-(2-(dimethylamino)ethylamin...)
Affinity DataKi:  17nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasmepsin II(Plasmodium falciparum)
Kyoto Pharmaceutical University

Curated by ChEMBL
LigandPNGBDBM50001066(CHEMBL3236060)
Affinity DataKi:  22nMAssay Description:Inhibition of Plasmodium falciparum plasmepsin 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM132916(US8846746, 194)
Affinity DataIC50:  0.700nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM132862(US8846746, 132)
Affinity DataIC50:  0.900nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM493926(US10988462, Example 37)
Affinity DataIC50:  0.980nMAssay Description:Human SGLT1-stably-expressing cell lines were seeded at 5×104 cells/well on BioCoat™ Poly-D-Lysine 96 well plate with Lid (Becton, Dickinson and Comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM109863(US8609647, 1 | US8609647, 15 | US8609647, 2 | US86...)
Affinity DataIC50:  1nMAssay Description:In the kinase reactions, fused proteins (6His tag-fused hJAK2 kinase domain (aa808-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NT...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM132882(US8846746, 154)
Affinity DataIC50:  1.10nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM133145(US8846746, 463)
Affinity DataIC50:  1.10nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetA disintegrin and metalloproteinase with thrombospondin motifs 4(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50167609((2R,5R)-1-[4-(2,4-Dichloro-benzyloxy)-benzenesulfo...)
Affinity DataIC50:  1.10nMAssay Description:Inhibition of human recombinant aggrecanase 1 after 150 mins by fluorescence plate readerMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Japan Tobacco

Curated by ChEMBL
LigandPNGBDBM50193995(3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr...)
Affinity DataIC50:  1.10nMAssay Description:Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM132870(US8846746, 140)
Affinity DataIC50:  1.10nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM132856(US8846746, 126)
Affinity DataIC50:  1.20nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMatrix metalloproteinase-14(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50341824((1S,2R,3R)-2-Methyl-1-[5-(4-methylpyrazol-1-yl)thi...)
Affinity DataIC50:  1.20nMAssay Description:Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate readerMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM493894(US10988462, Example 10)
Affinity DataIC50:  1.20nMAssay Description:Human SGLT1-stably-expressing cell lines were seeded at 5×104 cells/well on BioCoat™ Poly-D-Lysine 96 well plate with Lid (Becton, Dickinson and Comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM493905(US10988462, Example 20)
Affinity DataIC50:  1.20nMAssay Description:Human SGLT1-stably-expressing cell lines were seeded at 5×104 cells/well on BioCoat™ Poly-D-Lysine 96 well plate with Lid (Becton, Dickinson and Comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM493906(US10988462, Example 21)
Affinity DataIC50:  1.20nMAssay Description:Human SGLT1-stably-expressing cell lines were seeded at 5×104 cells/well on BioCoat™ Poly-D-Lysine 96 well plate with Lid (Becton, Dickinson and Comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM50193995(3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr...)
Affinity DataIC50:  1.20nMAssay Description:Inhibition of N-terminal GST-fused human JAK2 (880 to end residues) expressed in baculovirus infected Sf21 cells using TK-substrate-biotin as substra...More data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM132860(US8846746, 130)
Affinity DataIC50:  1.30nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM132929(US8846746, 208)
Affinity DataIC50:  1.30nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM493901(US10988462, Example 17)
Affinity DataIC50:  1.30nMAssay Description:Human SGLT1-stably-expressing cell lines were seeded at 5×104 cells/well on BioCoat™ Poly-D-Lysine 96 well plate with Lid (Becton, Dickinson and Comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMatrix metalloproteinase-14(Homo sapiens (Human))
Central Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50341816((1S,2R,3R)-1-[5-(4-Methoxypyrazol-1-yl)thiophene-2...)
Affinity DataIC50:  1.30nMAssay Description:Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate readerMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM132915(US8846746, 193)
Affinity DataIC50:  1.30nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM132874(US8846746, 144)
Affinity DataIC50:  1.30nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM132848(US8846746, 117)
Affinity DataIC50:  1.40nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM133143(US8846746, 461)
Affinity DataIC50:  1.40nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Japan Tobacco

US Patent
LigandPNGBDBM132924(US8846746, 203)
Affinity DataIC50:  1.40nMT: 2°CAssay Description:The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50288232(2-[2-(carboxymethoxy)-4-(2-{4H,5H,6H,7H-thieno[2,3...)
Affinity DataIC50:  1.40nMAssay Description:Inhibition of Vitronectin binding to GPIIb/IIIIa Vitronectin receptorMore data for this Ligand-Target Pair
In DepthDetails Article
Displayed 1 to 50 (of 1402 total ) | Next | Last >>
Jump to: